|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02279 YONGHE MEDICAL
Nominal 
0.850 0.000 (0.000%) Ranking Overview
Ranking based on 1 research report(s)
Average Ranking 4.00
|
Strong Buy (1)
0
|
Buy (2)
0
|
Hold (3)
0
|
Sell (4)
1
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | -108.00 RMB (cts) | |
| Net Profit | -546.39 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | -268.26 | -51.00 | -- | -268.26 | -268.26 | |
| 2025 | -54.16 | -10.00 | -- | -54.16 | -54.16 | |
| 2026 | 25.00 | 5.00 | -- | 25.00 | 25.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | -268.26 | -51.00 | -- | MORGAN STANLEY | Underweight | 0.90 | 07/07/2024 | |
| 2025 | -54.16 | -10.00 | -- | MORGAN STANLEY | -- | -- | 07/07/2024 | |
| 2026 | 25.00 | 5.00 | -- | MORGAN STANLEY | -- | -- | 07/07/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 20/12/2024 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -138,572,000 |
| %Change | -38.737% |
| EPS / (LPS) | RMB -0.280 |
| NBV Per Share (¥) | RMB 1.526 |